Your browser doesn't support javascript.
loading
Corrigendum: Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARSCoV-2 Nucleocapsid protein.
Visvabharathy, Lavanya; Hanson, Barbara A; Orban, Zachary S; Lim, Patrick H; Palacio, Nicole M; Jimenez, Millenia; Clark, Jeffrey R; Graham, Edith L; Liotta, Eric M; Tachas, George; Penaloza-MacMaster, Pablo; Koralnik, Igor J.
Afiliación
  • Visvabharathy L; Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
  • Hanson BA; Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
  • Orban ZS; Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
  • Lim PH; Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
  • Palacio NM; Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
  • Jimenez M; Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
  • Clark JR; Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
  • Graham EL; Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
  • Liotta EM; Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
  • Tachas G; Drug Discovery & Patents, Antisense Therapeutics Ltd., Melbourne, VIC, Australia.
  • Penaloza-MacMaster P; Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
  • Koralnik IJ; Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
Front Immunol ; 14: 1275925, 2023.
Article en En | MEDLINE | ID: mdl-37691950
[This corrects the article DOI: 10.3389/fimmu.2023.1155770.].
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza